PURE Bioscience Ships Initial Order to Italian Export Consortium, TICE

SAN DIEGO, CA--(Marketwired - June 07, 2013) - PURE Bioscience, Inc. (OTCQB: PURE), the creator of the patented silver dihydrogen citrate (SDC) antimicrobial, shipped an opening order of PURE Hard Surface and PURE Multi-Purpose Cleaner Concentrate to European distributor and Italian export consortium, TICE.

“We have placed this order as part of our initial campaign of customer trials and evaluation,” said Dosolino Marangon, president of TICE. “We have been receiving a positive response to our education and marketing campaigns for PURE products, and anticipate a successful product launch in Italy followed by introductions in more than 25 additional European countries.”

Since PURE announced its partnership with TICE in September 2012, TICE has been pursuing the necessary REACH requirements to distribute PURE’s disinfecting and cleaning products in the European Union. REACH, which stands for registration, evaluation, authorization and restriction of chemicals, represents the European Community’s regulation on chemicals and their safe use. REACH also mandates the progressive substitution of the most dangerous chemicals when suitable alternatives have been identified. TICE has filed the REACH pre-registration of PURE Hard Surface, PURE Multi-Purpose cleaner concentrate and PURE Floor Cleaner with the European Chemical Agency (ECHA), authorizing TICE by European law to import and distribute PURE Products throughout Europe.

“This shipment and the REACH filing are milestone events for our company,” said Michael L. Krall, PURE Bioscience’s president and CEO. “We appreciate the time, resources and investment TICE has committed to gain regulatory clearance for distribution of PURE products in Italy and elsewhere in Europe. We look forward to this first commercial launch of PURE across Europe.”

About TICE
TICE (The Italian Consortium Export) is a consortium composed of Italian companies who have as their main philosophy the promotion and sale of 100% made-in-Italy products, with an emphasis on the North American market. The product categories for TICE marketing include food and wine, production and process systems, renewable energy process systems, hospitality and restaurant decoration and design. Started on an experimental level in 2002, the TICE Consortium was officially founded in 2004 with a small number of companies. Over the years this number has grown, which has allowed TICE to create a network of business relationships in Italy, the United States and Mexico to execute innovative business concepts. For more information about TICE, visit www.tice.it.

About PURE Bioscience, Inc.
PURE Bioscience, Inc. develops and markets technology-based bioscience products that provide solutions to numerous global health challenges, including Staph (MRSA) and Carbapenem-resistant Enterobacteriaceae (CRE)/NDM-1+. PURE’s proprietary high efficacy/low toxicity bioscience technologies, including its silver dihydrogen citrate-based antimicrobials, represent innovative advances in diverse markets and lead today’s global trend toward industry and consumer use of “green” products while providing competitive advantages in efficacy and safety. Patented SDC is an electrolytically generated source of stabilized ionic silver, which formulates well with other compounds. As a platform technology, SDC is distinguished from competitors in the marketplace because of its superior efficacy, reduced toxicity and the inability of bacteria to form a resistance to it. PURE is headquartered in El Cajon, California (San Diego metropolitan area). Additional information on PURE is available at www.purebio.com.

About PURE Hard Surface
US EPA registered PURE Hard Surface disinfectant and food contact surface sanitizer provides an unparalleled combination of high efficacy and low toxicity with 30-second bacterial and viral kill times and 24-hour residual protection. SDC-based PURE Hard Surface completely kills resistant pathogens like MRSA and Carbapenem-resistant Klebsiella pneumoniae (NDM-1) and also effectively eliminates dangerous fungi and viruses including HIV, Hepatitis B, Hepatitis C, Norovirus, Influenza A, Avian Influenza and H1N1 as well as hazardous food pathogens such as E. coli, Salmonella and Campylobacter. PURE Hard Surface delivers powerful broad-spectrum efficacy while remaining classified as least-toxic (Category IV) by the US EPA, and its active ingredient, SDC, has been determined Generally Recognized as Safe (GRAS) for use as a biocide on food processing equipment, machinery and utensils.

About PURE Floor Cleaner and Multi-Purpose Concentrates
PURE’s non-toxic, environmentally responsible cleaning products are protected by SDC, a natural, non-toxic antimicrobial. SDC ensures the quality and safety of PURE Floor Cleaner and PURE Multi-Purpose Cleaner without human or environmental exposure to toxic chemical preservatives. PURE Floor Cleaner and PURE Multi-Purpose cleaner are non-flammable and contain no EDTA, phosphates, ammonia or bleach as well as no VOCs or NPEs. PURE Floor Cleaner and PURE Multi-Purpose Cleaner provide professional strength cleaning in a concentrate formula that yields a 1:128 use dilution that is safe for use on all resilient surfaces. The active ingredients in the cleaner products meet the US EPA’s DfE (Design for the Environment) Criteria for Safer Chemical Ingredients.

Forward-looking Statements
This press release includes statements that may constitute “forward-looking” statements, usually containing the words “believe,” “estimate,” “expect,” “intend,” “project” or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, the Company’s cash position and liquidity requirements, the Company’s failure to implement or otherwise achieve the benefits of its proposed initiatives and business plans, acceptance of the Company’s current and future products and services in the marketplace, the ability of the Company to develop effective new products and receive regulatory approvals of such products, competitive factors, dependence upon third-party vendors, and other risks detailed in the Company’s periodic report filings with the Securities and Exchange Commission. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release.